Infectious Diseases

Featured

  • Fotolia_24840259_Subscription_Monthly_L

    Report

    The Economic Costs of Antimicrobial Resistance

    Dec 11, 2014

    More and more bacterial and viral infections are resistant to antimicrobial drugs. But no new classes of antibiotics have entered the market for more than 25 years. Researchers estimate that failing to address this issue will mean a lower world population in 2050 than expected and at least $2 trillion in lost global GDP.

Explore Infectious Diseases

Research conducted by